EMA to review Takeda's hypertension candidate

The European Medicines Agency accepted for review an MAA from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) for azilsartan medoxomil ( TAK-491) to treat hypertension. The angiotensin II type 2 (AT2) rec...